Neuralstem President and CEO to Present NSI-566 Clinical Trials Program Update at BIO CEO & Investor Conference 2014 Feb 6, 2014
First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke Motor Deficits Jan 13, 2014
Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update Nov 12, 2013
Dr. Eva Feldman, Principal Investigator, to Give Update on ALS Trial at American Neurological Association Meeting Oct 10, 2013
University Of Michigan Health System Treats Its First Patients In Neuralstem's Phase II ALS Stem Cell Trial Oct 9, 2013